Skip to main content
NCBI home page
The Journal of Physiology logoLink to The Journal of Physiology
. 1970 Jul;208(3):515–546. doi: 10.1113/jphysiol.1970.sp009135

The metabolism of [3H]noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat

S Z Langer
PMCID: PMC1348785  PMID: 5499784

Abstract

1. The noradrenaline (NA) stores of the isolated medial muscle of the cat's nictitating membrane were labelled with [3H]NA and the tissue was set up in an isolated organ bath for field stimulation. The tritiated NA and its metabolites released spontaneously and by field stimulation were determined by scintillation counting following chromatographic separation.

2. NA represented 11·8 ± 1·0% of the total radioactivity of the spontaneously released tritiated compounds. The rest was accounted for by NA metabolites: (a) normetanephrine (NMN), 35%; (b) 4-hydroxy-3-methoxymandelic acid (VMA), 20%; (c) 3,4-dihydroxyphenylglycol (DOPEG), 10%; (d) 3,4-dihydroxymandelic acid (DOMA), 10%; (e) 4-hydroxy-3-methoxyphenylglycol (MOPEG), 14%.

3. Field stimulation at 25 shocks/sec with supramaximal stimuli of 1 msec duration increased the outflow of NA six to eightfold and that of NMN, DOPEG and VMA two to threefold. The increase in outflow of DOMA and MOPEG was small. NA represented 35·8 ± 4·1% of the total increase in radioactivity.

4. After pargyline pretreatment field stimulation increased the outflow of NA and NMN. Stimulation in the presence of pyrogallol raised the release of NA, DOMA and DOPEG. Neither pargyline nor pyrogallol affected the total release induced by stimulation.

5. Cocaine 0·3 μg/ml. increased the release due to stimulation at 4 shocks/sec but not at 25 shocks/sec. Cocaine did not affect the metabolism of the released transmitter.

6. Phenoxybenzamine (10 μg/ml.) increased release by stimulation at 4 and 25 shocks/sec. Metabolism of the released transmitter was prevented in the presence of phenoxybenzamine.

7. Phentolamine (3 μg/ml.), like phenoxybenzamine, blocked responses to field stimulation, but failed to modify release and subsequent metabolism of NA liberated by field stimulation.

8. The main NA metabolites in the rat vas deferens were DOPEG, DOMA and MOPEG. Stimulation at 4 shocks/sec resulted in an increased outflow of NA and of DOPEG. Fifty per cent of the total increase of radioactive compounds was accounted for by NA metabolites.

9. These experiments show that for the calculation of the actual output of transmitter it is important to include the metabolites and not to rely on the determination of [3H]NA alone.

Full text

PDF
515

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eisenfeld A. J., Axelrod J., Krakoff L. Inhibition of the extraneuronal accumulation and metabolism of norepinephrine by adrenergic blocking agents. J Pharmacol Exp Ther. 1967 Apr;156(1):107–113. [PubMed] [Google Scholar]
  2. Esterhuizen A. C., Graham J. D., Lever J. D., Spriggs T. L. Catecholamine and acetylcholinesterase distribution in relation to noradrenaline release. An enzyme histochemical and autoradiographic study on the innervation of the cat nictitating muscle. Br J Pharmacol Chemother. 1968 Jan;32(1):46–56. doi: 10.1111/j.1476-5381.1968.tb00428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HERTTING G., AXELROD J. Fate of tritiated noradrenaline at the sympathetic nerve-endings. Nature. 1961 Oct 14;192:172–173. doi: 10.1038/192172a0. [DOI] [PubMed] [Google Scholar]
  4. Häggendal J., Malmfors T. The effect of nerve stimulation on the uptake of noradrenaline into the adrenergic nerve terminals. Acta Physiol Scand. 1969 Jan-Feb;75(1):28–32. doi: 10.1111/j.1748-1716.1969.tb04351.x. [DOI] [PubMed] [Google Scholar]
  5. Iversen L. L., Jarrott B., Langer S. Z. Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea-pig vas deferens after sympathectomy. Br J Pharmacol. 1968 Nov;34(3):693P–694P. [PMC free article] [PubMed] [Google Scholar]
  6. Langer S. Z., Draskóczy P. R., Trendelenburg U. Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J Pharmacol Exp Ther. 1967 Aug;157(2):255–273. [PubMed] [Google Scholar]
  7. Langer S. Z., Trendelenburg U. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther. 1969 May;167(1):117–142. [PubMed] [Google Scholar]
  8. POTTER L. T., COOPER T., WILLMAN V. L., WOLFE D. E. SYNTHESIS, BINDING, RELEASE, AND METABOLISM OF NOREPINEPHRINE IN NORMAL AND TRANSPLANTED DOG HEARTS. Circ Res. 1965 May;16:468–481. doi: 10.1161/01.res.16.5.468. [DOI] [PubMed] [Google Scholar]
  9. Paton W. D., Vizi E. S. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol. 1969 Jan;35(1):10–28. doi: 10.1111/j.1476-5381.1969.tb07964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROSELL S., KOPIN I. J., AXELROD J. FATE OF H3-NORADRENALINE IN SKELETAL MUSCLE BEFORE AND FOLLOWING SYMPATHETIC STIMULATION. Am J Physiol. 1963 Aug;205:317–321. doi: 10.1152/ajplegacy.1963.205.2.317. [DOI] [PubMed] [Google Scholar]
  11. Smith C. B., Trendelenburg U., Langer S. Z., Tsai T. H. The relation of retention of norepineephrine-H3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J Pharmacol Exp Ther. 1966 Jan;151(1):87–94. [PubMed] [Google Scholar]
  12. THOMPSON J. W. Studies on the responses of the isolated nictitating membrane of the cat. J Physiol. 1958 Apr 3;141(1):46–72. doi: 10.1113/jphysiol.1958.sp005954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. TRENDELENBURG U. Modification of the effect of tyramine by various agents and procedures. J Pharmacol Exp Ther. 1961 Oct;134:8–17. [PubMed] [Google Scholar]
  14. TSAI T. H., FLEMING W. W. ANTAGONISM OF MONOAMINE OXIDASE INHIBITORS AGAINST NOREPINEPHRINE ACETYLCHOLINE AND POTASSIUM IN THE ISOLATED NICTITATING MEMBRANE OF THE CAT. J Pharmacol Exp Ther. 1965 Apr;148:40–47. [PubMed] [Google Scholar]
  15. Thoenen H., Hürlimann A., Haefely W. Dual site of action of phenoxybenzamine in the cat's spleen; blockade of alpha-adrenergic receptors and inhibition of re-uptake of neurally released norepinephrine. Experientia. 1964 May 15;20(5):272–273. doi: 10.1007/BF02151802. [DOI] [PubMed] [Google Scholar]
  16. VOGT M. The secretion of the denervated adrenal medulla of the cat. Br J Pharmacol Chemother. 1952 Jun;7(2):325–330. doi: 10.1111/j.1476-5381.1952.tb01329.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. VOGT M. Vasopressor, antidiuretic, and oxytocic activities of extracts of the dog's hypothalamus. Br J Pharmacol Chemother. 1953 Jun;8(2):193–196. doi: 10.1111/j.1476-5381.1953.tb00777.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Van Orden L. S., 3rd, Bensch K. G., Langer S. Z., Trendelenburg U. Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat. J Pharmacol Exp Ther. 1967 Aug;157(2):274–283. [PubMed] [Google Scholar]
  19. WALTMAN S., SEARS M. CATECHOL-O-METHYL TRANSFERASE AND MONOAMINE OXIDASE ACTIVITY IN THE OCULAR TISSUES OF ALBINO RABBITS. Invest Ophthalmol. 1964 Dec;3:601–605. [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES